Abstract
Loss of heterozygosity (LOH) has been frequently detected at chromosome 7q31 region in human head and neck squamous cell carcinomas (HNSCC) and many other cancers, suggesting the existence of tumor suppressor genes (TSG). We analysed LOH at 7q31 region in 49 HNSCC by using six polymorphic microsatellite markers and found allelic deletion in 48% (22/46) of the informative cases. We detected two preferentially deleted regions, one is around D7S643 and the other around D7S486. When we redefined the map of 7q31 region according to the contiguous sequences, a recently identified gene, ING3, was found in the proximity of D7S643. ING3 protein harbors the PHD domain highly homologous among ING family proteins, in which we previously found mutations in a related gene, ING1. As only one missense mutation of the ING3 gene was found in HNSCC, we examined the expression level. Reverse-transcription-PCR analysis demonstrated decreased or no expression of ING3 mRNA in 50% of primary tumors as compared with that of matched normal samples. Especially, about 63% of tongue and larynx tumors showed the decrease and a tendency of higher mortality was observed in cases with decreased ING3 expression. All these findings suggest a possibility that the ING3 gene functions as a TSG in a subset of HNSCC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bassam BJ, Caetano-Anolles G, Gresshoff PM . 1991 Anal. Biochem. 196: 80–83
Bieche I, Khodja A, Driouch K, Lidereau R . 1997 Clin. Cancer Res. 3: 1009–1016
Cowan JM, Beckett MA, Ahmed-Swan S, Weichselbaum RR . 1992 J. Natl. Cancer Inst. 84: 793–797
Edelson MI, Scherer SW, Tsui LC, Welch WR, Bell DA, Berkowitz RS, Mok SC . 1997 Oncogene 14: 2979–2984
Garkavtsev I, Kazarov A, Gudkov A, Riabowol K . 1996 Nat. Genet. 14: 415–420
Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM, Gudkov AV . 1998 Nature 391: 295–298
Gunduz M, Ouchida M, Fukushima K, Hanafusa H, Etani T, Nishioka S, Nishizaki K, Shimizu K . 2000 Cancer Res. 60: 3143–3146
Hinds PW, Weinberg RA . 1994 Curr. Opin. Genet. Dev. 4: 135–141
Hurlstone AFL, Reid G, Reeves JR, Fraser J, Strathdee G, Rahilly M, Parkinson EK, Black DM . 1999 Oncogene 18: 1881–1890
Knudson AG . 1993 Proc. Natl. Acad. Sci. USA 90: 10914–10921
Kohno T, Takakura S, Yamada T, Okamoto A, Tanaka T, Yokota J . 1999 Cancer Res. 59: 4170–4174
Kukita A, Kukita T, Maeda H, Ouchida M, Yatsuki H, Kohashi O . 1999 Blood 94: 1987–1997
Latil A, Cussenot O, Fournier G, Baron JC, Lidereau R . 1995 Clin. Cancer Res. 1: 1385–1389
Lin JC, Scherer SW, Tougas L, Traverso G, Tsui LC, Andrulis IL, Jothy S, Park M . 1996 Oncogene 13: 2001–2008
Loewith R, Meijer M, Lees-Miller S, Riabowol K, Young D . 2000 Mol. Cell. Biol. 20: 3807–3816
Nagashima M, Shiseki M, Miura K, Hagiwara K, Linke SP, Pedeux R, Wang XW, Yokota J, Riabowol K, Harris CC . 2001 Proc. Natl. Acad. Sci. USA 98: 9671–9676
Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M, Oishi M . 1993 Mol. Cell. Biol. 13: 6036–6043
Shimada Y, Saito A, Suzuki M, Takahashi E, Horie M . 1998 Cytogenet. Cell Genet. 83: 232–235
Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI . 1997 Oncogene 15: 2727–2733
Skowyra D, Zeremski M, Neznanov N, Li M, Choi Y, Uesugi M, Hauser CA, Gu W, Gudkov AV, Qin J . 2001 J. Biol. Chem. 276: 8734–8739
Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN, Jenkins RB . 1995 Cancer Res. 55: 4114–4119
Tanino M, Matsuo M, Uenaka A, Tsukuda K, Ouchida M, Nakayama E, Shimizu K . 1999 Mol. Carcinog. 26: 286–297
Tatarelli C, Linnenbach A, Mimori K, Croce CM . 2000 Genomics 68: 1–12
Toyama T, Iwase H, Watson P, Muzik H, Saettler E, Magliocco A, DiFrancesco L, Forsyth P, Garkavtsev I, Kobayashi S, Riabowol K . 1999 Oncogene 18: 5187–5193
Wang XL, Uzawa K, Miyakawa A, Shiiba M, Watanabe T, Sato T, Yokoe H, Tanizawa H . 1998 Int. J. Cancer 75: 671–674
Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, Giancotti FG . 1996 Cell 87: 733–743
Zenklusen JC, Thompson JC, Klein-Szanto AJP, Conti CJ . 1995 Cancer Res. 55: 1347–1350
Zenklusen JC, Oshimura M, Barrett JC, Conti CJ . 1994 Oncogene 9: 2817–2825
Zenklusen JC, Hodges LC, Lacava M, Green ED, Conti CJ . 2000 Oncogene 19: 1729–1733
Zenklusen JC, Conti CJ, Green ED . 2001 Nat. Genet. 27: 392–398
Zeremski M, Hill JE, Kwek SS, Grigorian IA, Gurova KV, Garkavtsev IV, Diatchenko L, Koonin EV, Gudkov AV . 1999 J. Biol. Chem. 274: 32172–32181
Zhang JS, Nelson M, Mciver B, Hay ID, Goellner JR, Grant CS, Eberhardt NL, Smith DI . 1998 Oncogene 17: 789–793
Acknowledgements
We would like to thank cell depositors, Drs M Urade, T Okabe and M Miyake for their kind approval for the cell distribution through cell bank. We thank T Fujiwara, A Sakai and H Hanafusa for technical support and the surgeons in the Department of Otolaryngology of our Medical School for providing fresh specimens. This work was supported by grants-in-aids from the Ministry of Education, Science, Sports and Culture and from the Ministry of Health and Welfare of Japan to K Shimizu.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gunduz, M., Ouchida, M., Fukushima, K. et al. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Oncogene 21, 4462–4470 (2002). https://doi.org/10.1038/sj.onc.1205540
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205540
Keywords
This article is cited by
-
Anesthesia Medications and Interaction with Chemotherapeutic Agents
Oncology and Therapy (2021)
-
Integrative analysis of mRNA-miRNA-TFs reveals the key regulatory connections involved in basal cell carcinoma
Archives of Dermatological Research (2020)
-
Plasma proteomic and autoantibody profiles reveal the proteomic characteristics involved in longevity families in Bama, China
Clinical Proteomics (2019)
-
INGs are potential drug targets for cancer
Journal of Cancer Research and Clinical Oncology (2017)
-
ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients
Tumor Biology (2016)